1. Coticchia JM, Chen M, Sachdeva L, Mutchnick S. New paradigms in the pathogenesis of otitis media in children. Front Pediatr. 2013; Dec. 1:52.
Article
2. Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM. Otitis media. Lancet. 2004; Feb. 363(9407):465–73.
Article
3. Infante-Rivard C, Fernandez A. Otitis media in children: frequency, risk factors, and research avenues. Epidemiol Rev. 1993; 15(2):44465.
Article
4. Klein JO. The burden of otitis media. Vaccine. 2000; Dec. 19 Suppl 1:S2–8.
Article
5. Al Khabori M, Khandekar R. The prevalence and causes of hearing impairment in Oman: a community-based cross-sectional study. Int J Audiol. 2004; Sep. 43(8):486–92.
Article
6. Heikkinen T, Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev. 2003; Apr. 16(2):230–41.
Article
7. Teele DW, Klein JO, Chase C, Menyuk P, Rosner BA. Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. Greater Boston Otitis Media Study Group. J Infect Dis. 1990; Sep. 162(3):685–94.
8. Lim DJ, Birck H. Ultrastructural pathology of the middle ear mucosa in serous otitis media. Ann Otol Rhinol Laryngol. 1971; Dec. 80(6):838–53.
Article
9. Tos M, Caye-Thomasen P. Mucous glands in the middle ear: what is known and what is not. ORL J Otorhinolaryngol Relat Spec. 2002; Mar-Apr. 64(2):86–94.
10. Bluestone CD, Klein JO. Otitis media with effusion, atelectasis, and Eustachian tube dysfunction. In : Bluestone CD, Stool SE, Arjona S, editors. Pediatric otolaryngology. Philadelphia (PA): Saunders;1983. p. 356–512.
11. Schuknecht HF. Pathology of the ear. Philadelphia (PA): Lea & Febiger;1993.
12. Ryan AF, Catanzaro A, Wasserman SI, Harris JP. Secondary immune response in the middle ear: immunological, morphological, and physiological observations. Ann Otol Rhinol Laryngol. 1986; May-Jun. 95(3 Pt 1):242–9.
Article
13. Cho CG, Pak K, Webster N, Kurabi A, Ryan AF. Both canonical and non-canonical NF-κB activation contribute to the proliferative response of the middle ear mucosa during bacterial infection. Innate Immun. 2016; Nov. 22(8):626–34.
Article
14. Hernandez M, Leichtle A, Pak K, Ebmeyer J, Euteneuer S, Obonyo M, et al. Myeloid differentiation primary response gene 88 is required for the resolution of otitis media. J Infect Dis. 2008; Dec. 198(12):1862–9.
Article
15. Leichtle A, Hernandez M, Pak K, Yamasaki K, Cheng CF, Webster NJ, et al. TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media. Innate Immun. 2009; Aug. 15(4):205–15.
Article
16. Ryan AF, Ebmeyer J, Furukawa M, Pak K, Melhus A, Wasserman SI, et al. Mouse models of induced otitis media. Brain Res. 2006; May. 1091(1):3–8.
Article
17. Palacios SD, Pak K, Kayali AG, Rivkin AZ, Aletsee C, Melhus A, et al. Participation of Ras and extracellular regulated kinase in the hyperplastic response of middle-ear mucosa during bacterial otitis media. J Infect Dis. 2002; Dec. 186(12):1761–9.
Article
18. Silini A, Parolini O, Huppertz B, Lang I. Soluble factors of amnionderived cells in treatment of inflammatory and fibrotic pathologies. Curr Stem Cell Res Ther. 2013; Jan. 8(1):6–14.
Article
19. Ricci E, Vanosi G, Lindenmair A, Hennerbichler S, Peterbauer-Scherb A, Wolbank S, et al. Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model. Cell Tissue Bank. 2013; Sep. 14(3):475–88.
Article
20. Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000; May. 19(3):348–52.
Article
21. Faulk WP, Matthews R, Stevens PJ, Bennett JP, Burgos H, Hsi BL. Human amnion as an adjunct in wound healing. Lancet. 1980; May. 1(8179):1156–8.
Article
22. Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, Lombardi G, et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation. 2004; Nov. 78(10):1439–48.
Article
23. Talmi YP, Sigler L, Inge E, Finkelstein Y, Zohar Y. Antibacterial properties of human amniotic membranes. Placenta. 1991; MayJun. 12(3):285–8.
Article
24. Kjaergaard N, Hein M, Hyttel L, Helmig RB, Schonheyder HC, Uldbjerg N, et al. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol. 2001; Feb. 94(2):224–9.
Article
25. Sangwan VS, Basu S. Antimicrobial properties of amniotic membrane. Br J Ophthalmol. 2011; Jan. 95(1):1–2.
Article
26. Gheorghe A, Pop M, Burcea M, Serban M. New clinical application of amniotic membrane transplant for ocular surface disease. J Med Life. 2016; Apr-Jun. 9(2):177–9.
27. Mohan R, Bajaj A, Gundappa M. Human amnion membrane: potential applications in oral and periodontal field. J Int Soc Prev Community Dent. 2017; Jan-Feb. 7(1):15–21.
Article
28. Mamede AC, Carvalho MJ, Abrantes AM, Laranjo M, Maia CJ, Botelho MF. Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Res. 2012; Aug. 349(2):447–58.
Article
29. Guo Q, Hao J, Yang Q, Guan L, Ouyang S, Wang J. A comparison of the effectiveness between amniotic membrane homogenate and transplanted amniotic membrane in healing corneal damage in a rabbit model. Acta Ophthalmol. 2011; Jun. 89(4):e315–9.
Article
30. Mahbod M, Shahhoseini S, Khabazkhoob M, Beheshtnejad AH, Bakhshandeh H, Atyabi F, et al. Amniotic membrane extract preparation: what is the best method. J Ophthalmic Vis Res. 2014; Jul-Sep. 9(3):314–9.
31. Yadav MK, Go YY, Kim SH, Chae SW, Song JJ. Antimicrobial and antibiofilm effects of human amniotic/chorionic membrane extract on Streptococcus pneumoniae. Front Microbiol. 2017; Oct. 8:1948.
Article
32. Cho CG, Gong SH, Kim HB, Song JJ, Park JH, Lim YS, et al. Role of group 3 innate lymphoid cells during experimental otitis media in a rat model. Int J Pediatr Otorhinolaryngol. 2016; Sep. 88:146–52.
Article
33. Yu GH, Kim HB, Ko SH, Kim YW, Lim YS, Park SW, et al. Expression of surfactant Protein-A in the Haemophilus influenzae-induced otitis media in a rat model. Int J Pediatr Otorhinolaryngol. 2018; Sep. 112:61–6.
Article
34. Go YY, Kim SE, Cho GJ, Chae SW, Song JJ. Promotion of osteogenic differentiation by amnion/chorion membrane extracts. J Appl Biomater Funct Mater. 2016; May. 14(2):e171–80.
Article
35. Go YY, Kim SE, Cho GJ, Chae SW, Song JJ. Differential effects of amnion and chorion membrane extracts on osteoblast-like cells due to the different growth factor composition of the extracts. PLoS One. 2017; Aug. 12(8):e0182716.
Article
36. Kim HA, Kim S, Chang SH, Hwang HJ, Choi YN. Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice. Int Immunopharmacol. 2007; Oct. 7(10):1286–91.
Article
37. He H, Li W, Chen SY, Zhang S, Chen YT, Hayashida Y, et al. Suppression of activation and induction of apoptosis in RAW264.7 cells by amniotic membrane extract. Invest Ophthalmol Vis Sci. 2008; Oct. 49(10):4468–75.
Article
38. Li W, He H, Kawakita T, Espana EM, Tseng SC. Amniotic membrane induces apoptosis of interferon-gamma activated macrophages in vitro. Exp Eye Res. 2006; Feb. 82(2):282–92.
39. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000; Mar. 182(3):311–22.
Article
40. Wang G, Xu Z, Wang R, Al-Hijji M, Salit J, Strulovici-Barel Y, et al. Genes associated with MUC5AC expression in small airway epithelium of human smokers and non-smokers. BMC Med Genomics. 2012; Jun. 5:21.
Article